Product information
From Health Canada
Current status:
Cancelled Pre Market
Current status date:
2021-06-28
Original market date: See footnote 1
Product name:
NEOSTIGMINE METHYLSULFATE INJECTION
DIN:
02243104 Electronic product monograph is not available
Company:
FRESENIUS KABI CANADA LTD
165 Galaxy Blvd, Suite 100
Toronto
Ontario
Canada
M9W 0C8
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Intravenous , Intramuscular , Subcutaneous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
12:04.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
N07AA01 NEOSTIGMINE
Active ingredient group (AIG) number:See footnote5
0102263002
Active ingredient(s) | Strength |
---|---|
NEOSTIGMINE METHYLSULFATE | 0.5 MG / ML |